PMC:7210461 / 5537-6168 JSONTXT

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T18","span":{"begin":226,"end":231},"obj":"Chemical"}],"attributes":[{"id":"A18","pred":"chebi_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"In conclusion, let us leave to scientists all over the world to develop an effective vaccine, which certainly would not be immediately useful in these days of raging pandemics, and, above all, the identification of biological drugs succeeding in blocking viral replication, especially in the prodromal and oligo-symptomatic phase of the disease. We should mainly care about what can be done in the second phase, when symptoms can indicate the way forward to prevent the third one, where full-blown complications require all the incomparable expertise of intensivists, to whom any necessary materials and equipment must be provided."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T3","span":{"begin":255,"end":272},"obj":"http://purl.obolibrary.org/obo/GO_0019079"},{"id":"T4","span":{"begin":255,"end":272},"obj":"http://purl.obolibrary.org/obo/GO_0019058"}],"text":"In conclusion, let us leave to scientists all over the world to develop an effective vaccine, which certainly would not be immediately useful in these days of raging pandemics, and, above all, the identification of biological drugs succeeding in blocking viral replication, especially in the prodromal and oligo-symptomatic phase of the disease. We should mainly care about what can be done in the second phase, when symptoms can indicate the way forward to prevent the third one, where full-blown complications require all the incomparable expertise of intensivists, to whom any necessary materials and equipment must be provided."}

{"project":"LitCovid-sentences","denotations":[{"id":"T33","span":{"begin":0,"end":345},"obj":"Sentence"},{"id":"T34","span":{"begin":346,"end":631},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In conclusion, let us leave to scientists all over the world to develop an effective vaccine, which certainly would not be immediately useful in these days of raging pandemics, and, above all, the identification of biological drugs succeeding in blocking viral replication, especially in the prodromal and oligo-symptomatic phase of the disease. We should mainly care about what can be done in the second phase, when symptoms can indicate the way forward to prevent the third one, where full-blown complications require all the incomparable expertise of intensivists, to whom any necessary materials and equipment must be provided."}